Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients - 11/12/19

Doi : 10.1016/j.jaad.2019.08.049

Alan Menter, MD ^a : Co-Chair, Kelly M. Cordoro, MD ^b, Dawn M.R. Davis, MD ^c, Daniela Kroshinsky, MD, MPH ^d, Amy S. Paller, MD ^e, April W. Armstrong, MD, MPH ^f, Cody Connor, MD ^g, Boni E. Elewski, MD ^g, Joel M. Gelfand, MD, MSCE ^h, Kenneth B. Gordon, MD ⁱ, Alice B. Gottlieb, MD, PhD ^j, Daniel H. Kaplan, MD, PhD ^k, Arthur Kavanaugh, MD ^l, Matthew Kiselica, BA/BS ^m, Dario Kivelevitch, MD ^a, Neil J. Korman, MD, PhD ⁿ, Mark Lebwohl, MD ^o, Craig L. Leonardi, MD ^p, Jason Lichten, MD ^m, Henry W. Lim, MD ^q, Nehal N. Mehta, MD, MSCE ^r, Sylvia L. Parra, MD ^s, Arun L. Pathy, MD ^t, Elizabeth A. Farley Prater, MD ^u, Reena N. Rupani, MD ^o, Michael Siegel, PhD ^v, Benjamin Stoff, MD, MA ^w, Bruce E. Strober, MD, PhD ^x,^y, Emily B. Wong, MD ^z, Jashin J. Wu, MD ^aa, Vidhya Hariharan, PhD ^bb,^⁎ , Craig A. Elmets, MD ^g : Co-Chair
^a Baylor University Medical Center, Dallas, Texas
^b University of California, San Francisco School of Medicine, Department of Dermatology, San Francisco, California
^c Mayo Clinic, Rochester, Minnesota
^d Massachusetts General Hospital, Boston, Massachusetts
^e Northwestern University Feinberg School of Medicine, Chicago, Illinois
^f University of Southern California, Los Angeles, California
^g University of Alabama, Birmingham, Alabama
^h University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
ⁱ Medical College of Wisconsin, Milwaukee, Wisconsin
^j Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York
^k University of Pittsburgh, Pittsburgh, Pennsylvania
^l University of San Diego, San Diego, California
^m National Psoriasis Foundation
ⁿ University Hospitals Cleveland Medical Center, Cleveland, Ohio
^o Icahn School of Medicine at Mount Sinai, New York, New York
^p Central Dermatology, St Louis, Missouri
^q Department of Dermatology, Henry Ford Medical Center, Detroit, Michigan
^r National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland
^s Dermatology and Skin Surgery, Sumter, South Carolina
^t Colorado Permanente Medical Group, Centennial, Colorado
^u University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
^v Pediatric Dermatology Research Alliance, Indianapolis, Indiana
^w Emory University School of Medicine, Atlanta, Georgia
^x Central Connecticut Dermatology, Cromwell, Connecticut
^y Yale University, New Haven, Connecticut
^z San Antonio Uniformed Services Health Education Consortium, Joint-Base San Antonio, Texas
^aa Dermatology Research and Education Foundation, Irvine, California
^bb American Academy of Dermatology, Rosemont, Illinois

^∗Correspondence to: Vidhya Hariharan, PhD, American Academy of Dermatology, 9500 W Bryn Mawr Ave, Rosemont, IL 60018.American Academy of Dermatology9500 W Bryn Mawr AveRosemontIL60018

In the version of this article that published online November 5, 2019 and in the January 2020 print issue there was a dosage error in Table XXXVII, recommendation number 18.3. The error has been corrected in this version of the article.

Abstract

Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children, with onset most common during adolescence. This guideline addresses important clinical questions that arise in psoriasis management and provides evidence-based recommendations. Attention will be given to pediatric patients with psoriasis, recognizing the unique physiology, pharmacokinetics, and patient-parent-provider interactions of patients younger than 18 years old. The topics reviewed here mirror those discussed in the adult guideline sections, excluding those topics that are irrelevant to, or lack sufficient information for, pediatric patients.

Le texte complet de cet article est disponible en PDF.

Key words : clinical guidelines for psoriasis, comorbidities, dermatology, guidelines, pediatric, pediatric psoriasis, psoriasis, psoriasis guidelines, skin disease

Abbreviations used : AAD, AAP, aHR, AOR, BMI, BSA, CDLQI, CI, FDA, GI, HPA, ICD, IL, LDL, NAFLD, NB, OR, PASI, PASI 75, PPD, PSA, PUVA, QOL, TCI, TNF, UV, UVA, UVB

Plan

	Funding sources: None.
	Conflicts of interest: Listed in text.
	Reprints not available from the authors.

Export

Vol 82 - N° 1

P. 161-201 - janvier 2020 Retour au numéro

Article précédent

Histopathologic features distinguishing secondary syphilis from its mimickers
Alexandra Flamm, Veronica Merelo Alcocer, Viktoryia Kazlouskaya, Eun Ji Kwon, Dirk Elston

| Article suivant

The human papillomavirus vaccine as a treatment for human papillomavirus–related dysplastic and neoplastic conditions: A literature review
Christine T. Pham, Margit Juhasz, Calvin T. Sung, Natasha Atanaskova Mesinkovska

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients - 11/12/19

Abstract

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL